Patents by Inventor Jens Ingwersen

Jens Ingwersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200024667
    Abstract: The present invention relates to methods of determining whether a patient responds to a therapeutic treatment of multiple sclerosis (MS), of monitoring the course of multiple sclerosis (MS) in a patient, of determining the risk for a relapse of multiple sclerosis (MS) in a patient, and of adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient. Said methods are based on the determination of the level of at least one miRNA in a test sample isolated from the patient. The present invention also relates to a method of identifying a compound suitable for the treatment of multiple sclerosis in a patient.
    Type: Application
    Filed: August 16, 2019
    Publication date: January 23, 2020
    Inventors: Andreas Keller, Markus Beier, Matthias Scheffler, Anke Wendschlag, Orhan Aktas, Jens Ingwersen, Hans-Peter Hartung, Patrick Kury, Timour Prozorovski
  • Patent number: 10428382
    Abstract: The present invention relates to methods of determining whether a patient responds to a therapeutic treatment of multiple sclerosis (MS), of monitoring the course of multiple sclerosis (MS) in a patient, of determining the risk for a relapse of multiple sclerosis (MS) in a patient, and of adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient. Said methods are based on the determination of the level of at least one miRNA in a test sample isolated from the patient. The present invention also relates to a method of identifying a compound suitable for the treatment of multiple sclerosis in a patient.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: October 1, 2019
    Assignee: Hummingbird Diagnostics GmbH
    Inventors: Andreas Keller, Markus Beier, Matthias Scheffler, Anke Wendschlag, Orhan Aktas, Jens Ingwersen, Hans-Peter Hartung, Patrick Küry, Timour Prozorovski
  • Publication number: 20160194712
    Abstract: The invention relates to methods of determining whether a patient responds to a therapeutic treatment of an autoimmune disease, of monitoring the course of an autoimmune disease in a patient, of determining the risk for a relapse of an autoimmune disease in a patient, and of adjusting the dose of a therapeutic drug applied for therapeutic treatment of an autoimmune disease in a patient. Said methods are based on the determination of the level of at least one miRNA in a test sample isolated from the patient. The invention also relates to a method of identifying a compound suitable for the treatment of an autoimmune disease in a patient.
    Type: Application
    Filed: September 3, 2014
    Publication date: July 7, 2016
    Inventors: Markus BEIER, Matthias SCHEFFLER, Orhan AKTAS, Jens INGWERSEN
  • Publication number: 20150037327
    Abstract: The present invention relates to methods of determining whether a patient responds to a therapeutic treatment of multiple sclerosis (MS), of monitoring the course of multiple sclerosis (MS) in a patient, of determining the risk for a relapse of multiple sclerosis (MS) in a patient, and of adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient. Said methods are based on the determination of the level of at least one miRNA in a test sample isolated from the patient. The present invention also relates to a method of identifying a compound suitable for the treatment of multiple sclerosis in a patient.
    Type: Application
    Filed: March 7, 2013
    Publication date: February 5, 2015
    Inventors: Andreas Keller, Markus Beier, Matthias Scheffler, Anke Wendschlag, Orhan Aktas, Jens Ingwersen, Hans-Peter Hartung, Patrick Küry, Timour Prozorovski